Literature DB >> 2212379

Early and late effects of captopril treatment after large myocardial infarction in rats.

R G Gay1.   

Abstract

The early (after 21 days) and late (after 4 months) effects of continuous treatment with captopril on left ventricular performance, weight and volumes were studied in rats with myocardial infarction. Early effects were examined in rats subjected to coronary ligation and randomized to either immediate treatment with captopril (2 g/liter drinking water) starting 2 h after surgery or no treatment. After 21 days, the treated group showed reductions in mean arterial, left ventricular systolic and left ventricular end-diastolic pressures compared with untreated rats. Right and left ventricular weight and left ventricular volumes were decreased and the ejection fraction index was increased by captopril treatment. To study the late effects of captopril, a second group of rats was randomized to immediate captopril treatment (starting 2 h after surgery), delayed captopril treatment (starting 21 days after surgery) or no treatment. When studied after 4 months of treatment, rats started on captopril treatment 2 h after infarction showed no differences compared with rats started on treatment 21 days after infarction. Treatment with captopril for 4 months produced changes that were similar to those in rats treated for 21 days. Captopril treatment improved hemodynamic function after myocardial infarction in rats examined after either 21 days or 4 months of treatment. The extent of the benefit was similar in the two treatment periods. Initiation of captopril therapy immediately after infarction did not appear to produce a greater effect than treatment started at 21 days after infarction in rats studied after the drug had been administered for 4 months.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212379     DOI: 10.1016/s0735-1097(10)80350-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Effects of Tongguan Capsule on post-myocardial infarction ventricular remodeling and cardiac function in rats.

Authors:  Bo-jun Chen; Jing-xi Feng; Xue-xu Su; Li-qin Meng; Zhi-shang Li; Yan-li Gao; Xiao-li Xia
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

2.  Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.

Authors:  K Takeuchi; T Omura; M Yoshiyama; K Yoshida; R Otsuka; Y Shimada; K Ujino; J Yoshikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

3.  Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.

Authors:  M Yoshiyama; Y Nakamura; T Omura; Y Izumi; R Matsumoto; S Oda; K Takeuchi; S Kim; H Iwao; J Yoshikawa
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

Review 4.  Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.

Authors:  I Crozier; H Ikram
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

5.  Effects of late reperfusion on infarct expansion and infarct healing in conscious rats.

Authors:  M Morita; S Kawashima; M Ueno; A Kubota; T Iwasaki
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

Review 6.  Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

Review 7.  The management of heart failure: a matter of definition?

Authors:  A Harley
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

8.  Reciprocal change in angiotensinogen mRNA expression in rat myocardium and liver after myocardial infarction.

Authors:  H S Kim; B H Oh; K H Han; S I Oh; T J Youn; C H Kim; M M Lee; Y B Park; Y S Choi; Y W Lee
Journal:  Heart Vessels       Date:  1998       Impact factor: 1.814

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.